Novartis and Drugs for Neglected Diseases initiative (DNDi) to collaborate on the development of a new oral drug to treat Visceral Leishmaniasis
 |
Novartis (Source: Novartis and DNDi | 5 years ago) |
Link |
|
Drugs for Neglected Diseases initiative (DNDi) (Source: Novartis and DNDi | 5 years ago) |
Link |
|
Novartis multimedia content (Source: Novartis and DNDi | 5 years ago) |
Link |